InVivoMab anti-mouse IL-2 BE0043-R025mg from Bio X Cell

Product Specs
ItemInVivoMab anti-mouse IL-2
CompanyBio X Cell
Price $2,183.00Supplier Page View Company Product Page
Catalog NumberBE0043-R025mg
Quantity25 mg
Applicationsin vivo Neutralization & Blocking
ConcentrationLot-Specific
Conjugate/TagUnconjugated
FormatPBS, pH 7.0, Contains no stabilizers or preservatives, Liquid
Purity≥95% Determined by SDS-PAGE
ReactivityMouse
IsotypeIgG2a, κ
CloneJES6-1A12
Hostrat
Antibody TypePrimary Antibody
ImmunogenRecombinant mouse IL-2
NCBI Full Gene Nameinterleukin 2
NCBI Gene AliasesIl-2
ClonalityMonoclonal
Research AreaCytokine and Chemokine, Immunology
StorageThe antibody solution should be stored at the stock concentration at 4°C. Do not freeze
Molecular Weight150 kDa
ModificationsNo
OriginUnited States

Endotoxin: ≤1EU/mg (≤0.001EU/µg), Determined by LAL gel clotting assay

Quantities Available: 1mg, 5mg, 25mg,50mg, 100mg, Additional Custom Sizing Available on bioxcell.com

39 Labombard Rd

Lebanon, NH 03766

United States

Phone: 1-866-787-3444

Email: customerservice@bioxcell.com

(2) ILC2s and T cells cooperate to ensure maintenance of M2 macrophages for lung immunity against hookwormsNature communicationsApril 27, 2015Bouchery T, Kyle R, Camberis M, Shepherd A, Filbey K, Smith A, Harvie M, Painter G, Johnston K, Ferguson P, et al.

(3) Differential requirement for IL-2 and IL-15 during bifurcated development of thymic regulatory T cellsJournal of immunology (Baltimore, Md. : 1950)December 1, 2014Marshall D, Sinclair C, Tung S, Seddon B.

(4) Effector CD4 T-cell transition to memory requires late cognate interactions that induce autocrine IL-2Nature communicationsNovember 5, 2014McKinstry KK, Strutt TM, Bautista B, Zhang W, Kuang Y, Cooper AM, Swain SL.

(5) Activated CD8+ T cells induce expansion of Vβ5+ regulatory T cells via TNFR2 signalingJournal of immunology (Baltimore, Md. : 1950)September 15, 2014Joedicke JJ, Myers L, Carmody AB, Messer RJ, Wajant H, Lang KS, Lang PA, Mak TW, Hasenkrug KJ, Dittmer U.

(6) IL-2 protects lupus-prone mice from multiple end-organ damage by limiting CD4-CD8- IL-17-producing T cellsJournal of immunology (Baltimore, Md. : 1950)September 1, 2014Mizui M, Koga T, Lieberman LA, Beltran J, Yoshida N, Johnson MC, Tisch R, Tsokos GC.

(7) IL-2-independent and TNF-α-dependent expansion of Vβ5+ natural regulatory T cells during retrovirus infectionJournal of immunology (Baltimore, Md. : 1950)June 1, 2013Myers L, Joedicke JJ, Carmody AB, Messer RJ, Kassiotis G, Dudley JP, Dittmer U, Hasenkrug KJ.

(8) CD4+CD25+ regulatory T cells control CD8+ T-cell effector differentiation by modulating IL-2 homeostasisProceedings of the National Academy of Sciences of the United States of AmericaMay 3, 2011McNally A, Hill GR, Sparwasser T, Thomas R, Steptoe RJ.

(10) Primed antigen-specific CD4+ T cells are required for NK cell activation in vivo upon Leishmania major infectionJournal of immunology (Baltimore, Md. : 1950)August 15, 2010Bihl F, Pecheur J, Bréart B, Poupon G, Cazareth J, Julia V, Glaichenhaus N, Braud VM.

(11) CARMA1 controls an early checkpoint in the thymic development of FoxP3+ regulatory T cellsJournal of immunology (Baltimore, Md. : 1950)June 1, 2009Molinero LL, Yang J, Gajewski T, Abraham C, Farrar MA, Alegre ML.

InVivoMab anti-mouse IL-2